Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study.

ABSTRACT: Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. Participants are staff employed in facilities managing people with proven or suspected COVID-19. As part of the study, we conducted a series of engagement sessions. The aims were to assess the feasibility of the study, to identify context-specific ethical issues, to understand possible concerns, to fine tune research procedures and to refine the COPCOV information materials. Methods: The COPCOV study was approved by relevant institutional review boards. The sessions described in this

SUBMITTER: Perrone C 

PROVIDER: S-EPMC9971639 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature